MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vissel, B.
Right arrow Articles by Westbrook, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vissel, B.
Right arrow Articles by Westbrook, G. L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*L-SERINE

Vol. 61, Issue 3, 595-605, March 2002

Intracellular Domains of NR2 Alter Calcium-Dependent Inactivation of N-Methyl-D-aspartate Receptors

Bryce Vissel, Johannes J. Krupp, Stephen F. Heinemann, and Gary L. Westbrook

Molecular Neurobiology Laboratory, the Salk Institute, La Jolla, California (B.V., S.F.H.); and the Vollum Institute, Oregon Health and Science University, Portland, Oregon (J.J.K., G.L.W.)

At central excitatory synapses, the transient elevation of intracellular calcium reduces N-methyl-D-aspartate (NMDA) receptor activity. Such `calcium-dependent inactivation' is mediated by interactions of calcium/calmodulin and alpha -actinin with the C terminus of NMDA receptor 1 (NR1) subunit. However, inactivation is also NR2-subunit specific, because it occurs in NR2A- but not NR2C-containing receptors. We examined the molecular basis for NR2-subunit specificity using chimeric and mutated NMDA receptor subunits expressed in HEK293 cells. We report that the intracellular loop immediately distal to the pore-forming P-loop M2 (M2-3 loop), as well as a short region in the C terminus, are involved in NR2-subunit specificity. Within the M2-3 loop, substitution of residue 619 in NR2A (valine) for the corresponding NR2C residue (isoleucine) reduced inactivation without affecting calcium permeability of the channel. In contrast, a Q620E mutation in NR2A reduced the relative calcium permeability without altering inactivation. Mutation of three serine/threonine residues in the M2-3 loop also reduced inactivation, as did substitution of the intracellular C terminus of NR2A for NR2C. We speculate that the M2-3 loop of NR2 modulates calcium-dependent inactivation by interacting with the NR1 C terminus, a region known to be essential for inactivation.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Bajaj, Y. Zhang, M. I. Schimerlik, A. M. Hau, J. Yang, T. M. Filtz, C. Kioussi, and J. E. Ishmael
N-Methyl-D-aspartate Receptor Subunits Are Non-myosin Targets of Myosin Regulatory Light Chain
J. Biol. Chem., January 9, 2009; 284(2): 1252 - 1266.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Petrovic, M. Sedlacek, M. Horak, H. Chodounska, and L. Vyklicky Jr
20-Oxo-5{beta}-Pregnan-3{alpha}-yl Sulfate Is a Use-Dependent NMDA Receptor Inhibitor
J. Neurosci., September 14, 2005; 25(37): 8439 - 8450.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics